Cutler Group LP Adma Biologics, Inc. Put Options Transaction History

Cutler Group LP

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 Apr 14, 2022	SELL	$1.28 - $1.83 $44,672 - $63,867	-34,900 Closed	0 $0
Q4 2021 Jan 18, 2022	BUY	$1.09 - $1.66 $5,232 - $7,968	4,800 Added 15.95%	34,900 $33,000
Q3 2021 Oct 26, 2021	SELL	$1.13 - $1.65 $31,300 - $45,705	-27,700 Reduced 47.92%	30,100 $43,000
Q2 2021 Jul 19, 2021	SELL	$1.51 - $2.07 $7,852 - $10,764	-5,200 Reduced 8.25%	57,800 $62,000
Q1 2021 Apr 26, 2021	BUY	$1.67 - $2.95 $65,297 - $115,345	39,100 Added 163.6%	63,000 $56,000
Q4 2020 Jan 21, 2021	BUY	$1.8 - $2.56 $39,780 - $56,576	22,100 Added 1227.78%	23,900 $10,000
Q3 2020 Oct 27, 2020	BUY	$2.04 - $3.74 $3,672 - $6,732	1,800 New	1,800 $1,000

312

184M

917K

91.6K

Ticker ADMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 196,356,992
Market Cap $3.16B
Description
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.